Member Info for Bladderman

Suggests our seller has stopped and we are sitting around £12M which is too cheap considering the potential and recent Aptamer group development LinkedIn update. Especially as we're underpinned by anticipated 2000L per day sanitizer production before the end of the month and 51.99p paid only last Thursday.

Very true Shear - clearly he doesn't understand COVID stock dynamics

Posted on the BRH Twitter feed. He said momentum will take us there.

Looking cheap sub 40p now

And that's without news

Yep - Trevor Brown TR1 ownership correction. Clearly these are being held tightly. All 27% of the company in fact. Less then 50% of shares in circulation tells you about the limited availability of stock. Clutch them tightly guys.

Aptamer's are just better all round than antibodies for such point of care tests which is why this potential device would certainly be highly desidesirable going forward

Airline evaluation is tanking EasyJet, British Airwats Virgin flights etc are all down significantly as currently their is no rapid point of care test on the market. We are looking to fullful that need and we are valued at sub £12M.

Hope peeps didn't follow Docs misunderstanding regarding BRH and sell sub 32p this morning. Noticed Belcourtoi is a strong advocate of this share

Bid firming, Ask going up with buys. Has the seller finished - certainly created unexpected opportunity. About to go BLUE

A few Pi's selling at sub £10M - good luck to them lol. MM aren't having mine for peanuts from this highly exciting novel Aptamer linked COVID play

Apology my bad - it was!

That was Wednesday - 5.6M was traded Thursday when BRH were notified. 2.5M Friday with 1M still to be declared. Could already be out or very close to. Explains a lot! Get ready for the bounce

He was pumping ICON recently which have no revenue but that's okay because Doc bought it, i.e the whole market is about opinions and this outfit has received unbalanced criticism from himself - toys out the pram springs to mind. Sounds to me like his failure to see opportunity amd value in these COVID plays has left him slightly bitter.

Additionally factor in the 2000L per day target by the end of May of critical sanitizer production which he claimed we should be giving away for free and it creates a picture.

Anyway enough of him and his trumpet. Exciting week coming up here!! Looking forward to the collaboration update

Doc will be surprised then that lock down won't finish tomorrow morning. Test test test is the WHO message and one wonders why. Sadly this pandemic is here to stay. He said profiteering from COVID but he's happy to rob locals of their natural resource from the third world and you know what they say about people in glass houses

I think what some de-rampers are trying to say that you have to wait until a company is £200M before investing which is the best way to make money on AIM lol

Disappointed by Doc and his dismissal of companys in the COVID space. We are living in unprecedented times and if one doesn't understand the science and the potential significance of developing of either a point of care test then that is fine or essential lab based diagnostic tools to controp the spread of disease then that is fine. If we dont teat we may have up to 6 waves of COVID outbreaks and already 30k plus have lost there lives in the UK alone as we are all fully aware. He has been exposed to be slightly out of his depth and sometimes it's best to say nothing at all.

The Aptamer approach is novel in this space and he ignored Aptamer's group involvement altogether as likely to not have done his research and of course one can't know everything about every company. Friday's development declared on Linked in is highly significant there is no doubt about that and these have been made incredible rapid progress and name claim to have COVIS specificity which is fantastic as we are all affected by this outbreak.

Also annoyingly he omitted the fact that we have ownership of company producing 5000L of sanitizer a day, of which we already have an NHS contract, is about to come online which at 30% production profit margin would generate £2M a year for BRH which by the way has been sold down to £10M so his comments regarding a £12-15M company is slightly inaccurate so at least get that bit right lol.

On Thursday 5.6M was traded - even Friday we had 2.6M of which 1.6M was reported and still have 1M outstanding

Well spotted Leonsniper.

Cytiva liking Aptamer development linkedin update suggest they are all over this.

Also love the fact from nothing BRH has 50% exposure to increased sanitizer production after a manufacturing switch under pins our markwt cap (£2M per annum profit potential).

Sentinel Medical Limited ("Sentinel") (holding 38.38%)

As previously reported, Sentinel has a licence to use Paraytec's imaging technology to detect bladder cancer and has ongoing trials with bladder cancer patient samples, to develop a point-of-care instrument. It has submitted a grant application with University of Sheffield, Aptamer Group and the Leeds Teaching Hospitals NHS Trust, to enhance this product using aptamers.

Point of care instrument in development - interesting. We potential have a head platform for the Aptamer to bind too.

This is going to be special. Algamers have huge advantages over antibody use (like ODX's device).
We'll provide the beads and point of care device. Anticipate news on this very exciting partnership/collaboration development.

This milestone cannot be understated - said they were progressing rapidly!